GLMD vs. ICAD

Last updated Jun 3, 2026

GLMD (Galmed Pharmaceuticals Ltd.) and ICAD (iCAD, Inc.) are both stocks. Both are in the Healthcare sector — GLMD in Biotechnology, ICAD in Health Information Services. At a 0.14 correlation, their price movements are largely independent.

Performance

GLMD vs. ICAD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Galmed Pharmaceuticals Ltd. (GLMD) and iCAD, Inc. (ICAD). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

GLMD

• 1D: -4.96%
• 1M: 21.01%
• YTD: -7.91%
• 6M: -27.93%
• 1Y: -52.34%
• 3Y*: -77.01%
• 5Y*: -73.13%
• 10Y*: -50.21%

ICAD

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

GLMD vs. ICAD - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
GLMD Galmed Pharmaceuticals Ltd.	-7.91%	-76.47%	-41.58%	-93.93%	-72.53%	-41.48%	-46.19%	-15.37%	-25.36%	160.68%
ICAD iCAD, Inc.	0.00%	111.48%	3.39%	-3.28%	-74.58%	-45.45%	69.88%	110.00%	7.56%	6.34%

Correlation

The correlation between GLMD and ICAD is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.17
Correlation (3Y) Calculated over the trailing 3-year period	0.17
Correlation (5Y) Calculated over the trailing 5-year period	0.16
Correlation (10Y) Calculated over the trailing 10-year period	0.15
Correlation (All Time) Calculated using the full available price history since Mar 14, 2014	0.14

Fundamentals

Total Revenue (TTM) GLMD : $0.00 ICAD : $19.53M
Gross Profit (TTM) GLMD : $0.00 ICAD : $16.77M
EBITDA (TTM) GLMD : -$8.49M ICAD : -$4.84M

Return for Risk

GLMD vs. ICAD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GLMD

GLMD Risk / Return Rank: 17
GLMD Sharpe Ratio Rank: 14
GLMD Sortino Ratio Rank: 17
GLMD Omega Ratio Rank: 18
GLMD Calmar Ratio Rank: 17
GLMD Martin Ratio Rank: 21

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GLMD vs. ICAD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Galmed Pharmaceuticals Ltd. (GLMD) and iCAD, Inc. (ICAD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	GLMD	ICAD	Difference
Sharpe ratio Return per unit of total volatility	-0.61	—	—
Sortino ratio Return per unit of downside risk	-0.63	—	—
Omega ratio Gain probability vs. loss probability	0.93	—	—
Calmar ratio Return relative to maximum drawdown	-0.65	—	—
Martin ratio Return relative to average drawdown	-0.93	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	GLMD	ICAD	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.61	—	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.44	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.37	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.38	—	—

Drawdowns

Drawdown Indicators

	GLMD	ICAD	Difference
Max Drawdown Largest peak-to-trough decline	-99.99%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-79.62%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-99.16%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-99.93%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-99.99%	—	—
Current Drawdown Current decline from peak	-99.98%	—	—
Average Drawdown Average peak-to-trough decline	-74.34%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	55.31%	—	—

Volatility

Volatility by Period

	GLMD	ICAD	Difference
Volatility (1M) Calculated over the trailing 1-month period	25.26%	—	—
Volatility (6M) Calculated over the trailing 6-month period	62.71%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	86.30%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	166.32%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	137.60%	—	—

Dividends

GLMD vs. ICAD - Dividend Comparison

Neither GLMD nor ICAD has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both GLMD and ICAD in my portfolio?

GLMD and ICAD have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.